{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:41:30Z","timestamp":1791301290338,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"European Union Seventh Framework Programme","doi-asserted-by":"crossref","award":["HEALTH F2 2007 202088"],"award-info":[{"award-number":["HEALTH F2 2007 202088"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.toxicon.2013.10.013","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T18:15:56Z","timestamp":1381947356000},"page":"270-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Analytical workflow for rapid screening and purification of bioactives from venom proteomes"],"prefix":"10.1016","volume":"76","author":[{"given":"Reka A.","family":"Otvos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferry","family":"Heus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freek J.","family":"Vonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Halff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Bruyneel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Paliukhovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"August B.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried M.A.","family":"Niessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Kool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2013.10.013_bib1","doi-asserted-by":"crossref","first-page":"12836","DOI":"10.1021\/bi971513u","article-title":"Nonidentity of the alpha-neurotoxin binding sites on the nicotinic acetylcholine receptor revealed by modification in alpha-neurotoxin and receptor structures","volume":"36","author":"Ackermann","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2013.10.013_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425240802650568","article-title":"PEG-modified biopharmaceuticals","volume":"6","author":"Bailon","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.toxicon.2013.10.013_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157488610792246037","article-title":"Immunotoxicity and immunogenicity of biopharmaceuticals: design concepts and safety assessment","volume":"5","author":"Bhogal","year":"2010","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.toxicon.2013.10.013_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/35077011","article-title":"Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors","volume":"411","author":"Brejc","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2013.10.013_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/1091581809337262","article-title":"Alternative strategies for toxicity testing of species-specific biopharmaceuticals","volume":"28","author":"Bussiere","year":"2009","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.toxicon.2013.10.013_bib6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nsmb951","article-title":"Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant","volume":"12","author":"Celie","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.toxicon.2013.10.013_bib7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/096470490881770","article-title":"Contribution of a snake venom toxin to myasthenia gravis: the discovery of alpha-bungarotoxin in Taiwan","volume":"14","author":"Chu","year":"2005","journal-title":"J. Hist. Neurosci."},{"key":"10.1016\/j.toxicon.2013.10.013_bib8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.tplants.2009.09.009","article-title":"Plant-made vaccine antigens and biopharmaceuticals","volume":"14","author":"Daniell","year":"2009","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.toxicon.2013.10.013_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.chroma.2006.01.059","article-title":"High-performance liquid chromatography\u2013mass spectrometry-based acetylcholinesterase assay for the screening of inhibitors in natural extracts","volume":"1112","author":"de Jong","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.toxicon.2013.10.013_bib10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1039\/c1md00031d","article-title":"Online parallel fragment screening and rapid hit exploration for nicotinic acetylcholine receptors","volume":"2","author":"de Kloe","year":"2011","journal-title":"MedChemComm"},{"key":"10.1016\/j.toxicon.2013.10.013_bib11","doi-asserted-by":"crossref","first-page":"7192","DOI":"10.1021\/jm100834y","article-title":"Surface plasmon resonance biosensor based fragment screening using acetylcholine binding protein identifies ligand efficiency hot spots (LE hot spots) by deconstruction of nicotinic acetylcholine receptor alpha7 ligands","volume":"53","author":"de Kloe","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.toxicon.2013.10.013_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00449-007-0151-y","article-title":"Current achievements in the production of complex biopharmaceuticals with moss bioreactors","volume":"31","author":"Decker","year":"2008","journal-title":"Bioproc. Biosyst. Eng."},{"key":"10.1016\/j.toxicon.2013.10.013_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/02648725.2004.10648053","article-title":"Polymeric delivery systems for biopharmaceuticals","volume":"21","author":"Dinarvand","year":"2004","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.toxicon.2013.10.013_bib14","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1038\/sj.emboj.7601785","article-title":"AChBP-targeted alpha-conotoxin correlates distinct binding orientations with nAChR subtype selectivity","volume":"26","author":"Dutertre","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.toxicon.2013.10.013_bib15","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1021\/ja110571r","article-title":"Fragment growing induces conformational changes in acetylcholine-binding protein: a structural and thermodynamic analysis","volume":"133","author":"Edink","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.toxicon.2013.10.013_bib16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/pmic.200700777","article-title":"Exploring snake venom proteomes: multifaceted analyses for complex toxin mixtures","volume":"8","author":"Fox","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.toxicon.2013.10.013_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00239-003-2461-2","article-title":"Molecular evolution and phylogeny of elapid snake venom three-finger toxins","volume":"57","author":"Fry","year":"2003","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.toxicon.2013.10.013_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2165\/11316550-000000000-00000","article-title":"Pharmacovigilance of biopharmaceuticals: challenges remain","volume":"32","author":"Giezen","year":"2009","journal-title":"Drug Saf."},{"key":"10.1016\/j.toxicon.2013.10.013_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2006.06.032","article-title":"Applications of carrier erythrocytes in delivery of biopharmaceuticals","volume":"118","author":"Hamidi","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.toxicon.2013.10.013_bib20","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1007\/s00216-010-4210-x","article-title":"Development of a microfluidic confocal fluorescence detection system for the hyphenation of nano-LC to on-line biochemical assays","volume":"398","author":"Heus","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.toxicon.2013.10.013_bib21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.toxicon.2012.11.002","article-title":"An efficient analytical platform for on-line microfluidic profiling of neuroactive snake venoms towards nicotinic receptor affinity","volume":"61","author":"Heus","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2013.10.013_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1568007043482507","article-title":"Nicotinic acetylcholine receptors as drug targets","volume":"3","author":"Hogg","year":"2004","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.toxicon.2013.10.013_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10254-003-0005-1","article-title":"Nicotinic acetylcholine receptors: from structure to brain function","volume":"147","author":"Hogg","year":"2003","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"issue":"Suppl. 5","key":"10.1016\/j.toxicon.2013.10.013_bib24","doi-asserted-by":"crossref","first-page":"v9","DOI":"10.1093\/ndt\/gfl476","article-title":"Immunogenicity of biopharmaceuticals","volume":"21","author":"Kessler","year":"2006","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.toxicon.2013.10.013_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrd1657","article-title":"The evolving role of natural products in drug discovery","volume":"4","author":"Koehn","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.toxicon.2013.10.013_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1586\/erv.10.85","article-title":"Transient expression systems for plant-derived biopharmaceuticals","volume":"9","author":"Komarova","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.toxicon.2013.10.013_bib27","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1021\/jm100230k","article-title":"Online fluorescence enhancement assay for the acetylcholine binding protein with parallel mass spectrometric identification","volume":"53","author":"Kool","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.toxicon.2013.10.013_bib28","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1007\/s00216-010-4406-0","article-title":"Advances in mass spectrometry-based post-column bioaffinity profiling of mixtures","volume":"399","author":"Kool","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.toxicon.2013.10.013_bib29","doi-asserted-by":"crossref","first-page":"15388","DOI":"10.1021\/bi001825o","article-title":"Orientation of alpha-neurotoxin at the subunit interfaces of the nicotinic acetylcholine receptor","volume":"39","author":"Malany","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2013.10.013_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/1091581810378896","article-title":"Developmental toxicity testing of biopharmaceuticals in nonhuman primates: previous experience and future directions","volume":"29","author":"Martin","year":"2010","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.toxicon.2013.10.013_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tips.2004.05.006","article-title":"Techniques: new approaches to the delivery of biopharmaceuticals","volume":"25","author":"Orive","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.toxicon.2013.10.013_bib32","doi-asserted-by":"crossref","unstructured":"Petras, D., Sanz, L., Segura, A., Herrera, M., Villalta, M., Solano, D., Vargas, M., Leon, G., Warrell, D.A., Theakston, R.D., Harrison, R.A., Durfa, N., Nasidi, A., Gutierrez, J.M., Calvete, J.J. Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the pan-African EchiTAb-Plus-ICP antivenom by antivenomics and neutralization approaches. J. Proteome Res. 10, 1266\u20131280.","DOI":"10.1021\/pr101040f"},{"key":"10.1016\/j.toxicon.2013.10.013_bib33","first-page":"216","article-title":"License compliance issues for biopharmaceuticals: special challenges for negotiations between companies and non-profit research institutions","volume":"46","author":"Ponzio","year":"2011","journal-title":"LES Nouv."},{"key":"10.1016\/j.toxicon.2013.10.013_bib34","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0041-0101(95)00096-5","article-title":"A novel analgesic toxin (hannalgesin) from the venom of king cobra (Ophiophagus hannah)","volume":"33","author":"Pu","year":"1995","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2013.10.013_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nbt0210-107","article-title":"Pfizer stakes a claim in plant cell-made biopharmaceuticals","volume":"28","author":"Ratner","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.toxicon.2013.10.013_bib36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0167-7799(00)01473-6","article-title":"New biopharmaceuticals in the USA: trends in development and marketing approvals 1995\u20131999","volume":"18","author":"Reichert","year":"2000","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.toxicon.2013.10.013_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0939-6411(00)00131-4","article-title":"Biopharmaceuticals approved in the EU 1995\u20131999: a European Union\u2013United States comparison","volume":"51","author":"Reichert","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.toxicon.2013.10.013_bib38","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1074\/jbc.M109.074161","article-title":"Structural and functional characterization of a novel homodimeric three-finger neurotoxin from the venom of Ophiophagus hannah (king cobra)","volume":"285","author":"Roy","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2013.10.013_bib39","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.addr.2006.07.010","article-title":"Particle engineering techniques for inhaled biopharmaceuticals","volume":"58","author":"Shoyele","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.toxicon.2013.10.013_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/35077000","article-title":"A glia-derived acetylcholine-binding protein that modulates synaptic transmission","volume":"411","author":"Smit","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2013.10.013_bib41","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1021\/bm700540p","article-title":"Delivery of large biopharmaceuticals from cardiovascular stents: a review","volume":"8","author":"Takahashi","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.toxicon.2013.10.013_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.phytochem.2003.07.001","article-title":"Rapid dereplication of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical detection coupled to mass spectrometry","volume":"65","author":"van Elswijk","year":"2004","journal-title":"Phytochemistry"},{"key":"10.1016\/j.toxicon.2013.10.013_bib43","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.toxicon.2013.10.013_bib44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/bies.201000117","article-title":"Snake venom: from fieldwork to the clinic: recent insights into snake biology, together with new technology allowing high-throughput screening of venom, bring new hope for drug discovery","volume":"33","author":"Vonk","year":"2011","journal-title":"Bioessays"},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2013.10.013_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000107094","article-title":"Manufacturing of biopharmaceuticals and implications for biosimilars","volume":"30","author":"Wurm","year":"2007","journal-title":"Kidney Blood Press Res."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010113003991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010113003991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T15:30:35Z","timestamp":1589211035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010113003991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":45,"alternative-id":["S0041010113003991"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.10.013","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical workflow for rapid screening and purification of bioactives from venom proteomes","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}